Interaction of Occupational Toxic Metal Burden with HIV Status and Increased Cancer Risk

Udah D. C.

Laboratory for Toxicology and Micronutrient Metabolism, Department of Chemical Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Bakarey A. S.

Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Anetor G. O.

Department of Public Health Science, Faculty of Health Sciences, National Open University of Nigeria (NOUN), Abuja, Nigeria.

Uche Z. C.

Laboratory for Toxicology and Micronutrient Metabolism, Department of Chemical Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Omabe M.

Department of Medical Laboratory Sciences, School of Biomedical Science, Faculty of Health Science, Ebonyi State University, Nigeria.

Akinwande K. S.

Department of Chemical Pathology and Immunology, Federal Medical Centre, Abeokuta, Ogun State, Nigeria.

Ademowo O. G.

Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Anetor J. I. *

Laboratory for Toxicology and Micronutrient Metabolism, Department of Chemical Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria.

*Author to whom correspondence should be addressed.


Abstract

Aims: This study aimed to investigate the effects of HIV infection and occupational exposure on the concentrations of selected toxic metals and essential trace elements such as zinc in relation to the carcinogenic process.

Study Design: Comparative cross-sectional study.

Place and Duration of Study: Participants were recruited from two local government areas (Calabar municipal and Calabar south) and one secondary health facility in Calabar, Nigeria from April 2017 to February 2018.

Methodology: Study participants comprising 248 adults (191 males, 57 females, aged 18-65 years) were divided into four groups based on HIV status and occupational exposure to toxic metals: HIV-positive exposed (HPE; n=62), HIV-positive unexposed (HPU; n=66), HIV-negative exposed (HNE; n=60), and HIV-negative unexposed (HNU; n=60). The HIV-positive and HIV-negative groups had similar occupations, ages, and other characteristics. Blood cadmium (Cd), lead (Pb), mercury (Hg) and selenium (Se) were measured by inductively coupled plasma optical emission spectrometry (ICP-OES), while serum zinc (Zn) and copper (Cu) were determined using atomic absorption spectrometry.

Results: Lead, cadmium, and mercury were significantly elevated in HPE (14.92 ± 0.54 μg/dl, 0.25 ± 0.01 μg/L, 1.93 ± 0.08 μg/L respectively) compared with the HNU (11.07 ± 0.48 μg/dl, 0.17 ± 0.01 μg/L, 0.76 ± 0.05 μg/L), p<0.01, respectively. Zinc, a well-known antioxidant, p53 activator, and cell cycle regulator, was significantly lower in the HPE than in HPU, HNE, and HNU (p=0.02, p<0.01, p<0.01 respectively). Toxic metal exposure and HIV-positive status were associated with increased Pb and Hg levels as well as decreased Zn, suggesting additive effects.

Conclusion: Occupationally exposed HIV-positive individuals exhibited a higher toxic metal burden and a lower zinc level, both of which are important determinants of genome instability and may exacerbate DNA damage as well as impair DNA repair, raising cancer risk. Further studies with a larger sample size may fully elucidate the mechanisms underlying the interaction between HIV infection and occupational toxic metal exposure.

Keywords: Human immunodeficiency virus, occupational exposure, toxic metal, cancer risk


How to Cite

Udah D. C., Bakarey A. S., Anetor G. O., Uche Z. C., Omabe M., Akinwande K. S., Ademowo O. G., & Anetor J. I. (2023). Interaction of Occupational Toxic Metal Burden with HIV Status and Increased Cancer Risk. International Research Journal of Oncology, 6(2), 191–202. Retrieved from https://journalirjo.com/index.php/IRJO/article/view/138

Downloads

Download data is not yet available.

References

Carlson RW, Scavone JL, Koh W-J, McClure JS, Greer BE, Kumar R, et al. NCCN Framework for Resource Stratification: A Framework for Providing and Improving Global Quality Oncology Care. J Natl Compr Canc Netw. 2016; 14(8):961–969.

DOI: 10.6004/jnccn.2016.0103

de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: A worldwide incidence analysis. Lancet Glob Heal. 2020;8(2):e180–e190.

DOI: 10.1016/S2214-109X(19)30488-7

Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31–54.

DOI: 10.3322/caac.21440

Odutola M, Jedy-Agba EE, Dareng EO, Oga EA, Igbinoba F, Otu T, et al. Burden of Cancers Attributable to Infectious Agents in Nigeria: 2012-2014. Front Oncol. 2016;6:216.

DOI: 10.3389/fonc.2016.00216

Rehman K, Fatima F, Waheed I, Akash MSH. Prevalence of exposure of heavy metals and their impact on health consequences. J Cell Biochem. 2018; 119(1):157–184.

DOI: 10.1002/jcb.26234

Sauvé J-F, Ramsay JM, Locke SJ, Dopart PJ, Josse PR, Zaebst DD, et al. Validity of retrospective occupational exposure estimates of lead and manganese in a case-control study. Occup Environ Med. 2019;76(9):680–687.

DOI: 10.1136/oemed-2019-105744

Salemi R, Marconi A, Di Salvatore V, Franco S, Rapisarda V, Libra M. Epigenetic alterations and occupational exposure to benzene, fibers, and heavy metals associated with tumor development (Review). Mol Med Rep. 2017;15(5):3366–3371.

DOI: 10.3892/mmr.2017.6383

Moura LTR de, Bedor CNG, Lopez RVM, Santana VS, Rocha TMB da S da, Wünsch Filho V, et al. Occupational exposure to organophosphate pesticides and hematologic neoplasms: A systematic review. Rev Bras Epidemiol. 2020;23: e200022.

DOI: 10.1590/1980-549720200022

Latifovic L, Villeneuve PJ, Parent M-É, Johnson KC, Kachuri L, Harris SA. Bladder cancer and occupational exposure to diesel and gasoline engine emissions among Canadian men. Cancer Med. 2015;4(12):1948–1962.

DOI: 10.1002/cam4.544

Carey RN, Hutchings SJ, Rushton L, Driscoll TR, Reid A, Glass DC, et al. The future excess fraction of occupational cancer among those exposed to carcinogens at work in Australia in 2012. Cancer Epidemiol. 2017;47:1–6.

DOI: 10.1016/j.canep.2016.12.009

Son Y-O. Molecular mechanisms of nickel-induced carcinogenesis. Endocr Metab Immune Disord Drug Targets; 2019.

DOI: 10.2174/1871530319666191125112728

Kim S, Yoon C, Ham S, Park J, Kwon O, Park D, et al. Chemical use in the semiconductor manufacturing industry. Int J Occup Environ Health. 2018;24(3–4):109–118. DOI: 10.1080/10773525.2018.1519957

Patrick L. Toxic metals and antioxidants: Part II. The role of antioxidants in arsenic and cadmium toxicity. Alternative Medicine Review. 2003 May 1;8(2).

Jones DR, Jarrett JM, Tevis DS, Franklin M, Mullinix NJ, Wallon KL, et al. Analysis of whole human blood for Pb, Cd, Hg, Se, and Mn by ICP-DRC-MS for biomonitoring and acute exposures. Talanta. 2017; 162:114–122.

Smith JCJ, Butrimovitz GP, Purdy WC. Direct measurement of zinc in plasma by atomic absorption spectroscopy. Clin Chem. 1979;25(8):1487–1491.

Osheim DL. Atomic absorption determination of serum copper: collaborative study. J Assoc Off Anal Chem. 1983;66(5):1140–1142.

Xu X, Hu H, Dailey AB, Kearney G, Talbott EO, Cook RL. Potential health impacts of heavy metals on HIV-infected population in USA. PLoS One. 2013;8(9):e74288.

DOI: 10.1371/journal.pone.0074288

Emokpae MA, Mbonu I. Blood levels of some toxic metals in Human Immunodeficiency Virus (HIV) Type 1-infection. Ann Heal Res. 2018;4(1):75– 81.

Folorunso OM, Frazzoli C, Chijioke-Nwauche I, Bocca B, Orisakwe OE. Toxic Metals and Non-Communicable Diseases in HIV Population: A Systematic Review. Medicina (Kaunas). 2021;57(5).

DOI: 10.3390/medicina57050492

Calao-Ramos C, Bravo AG, Paternina-Uribe R, Marrugo-Negrete J, Díez S. Occupational human exposure to mercury in artisanal small-scale gold mining communities of Colombia. Environ Int. 2021;146:106216.

DOI: 10.1016/j.envint.2020.106216

Mambrey V, Rakete S, Tobollik M, Shoko D, Moyo D, Schutzmeier P, et al. Artisanal and small-scale gold mining: A cross-sectional assessment of occupational mercury exposure and exposure risk factors in Kadoma and Shurugwi, Zimbabwe. Environ Res. 2020;184: 109379.

DOI: 10.1016/j.envres.2020.109379

Kuras R, Reszka E, Wieczorek E, Jablonska E, Gromadzinska J, Malachowska B, et al. Biomarkers of selenium status and antioxidant effect in workers occupationally exposed to mercury. J trace Elem Med Biol organ Soc Miner Trace Elem. 2018;49:43– 50.

DOI: 10.1016/j.jtemb.2018.04.032

Eisler R. Health risks of gold miners: A synoptic review. Environ Geochem Health. 2003;25(3):325–345.

DOI: 10.1023/a:1024573701073.

Zefferino R, Piccoli C, Ricciardi N, Scrima R, Capitanio N. Possible Mechanisms of Mercury Toxicity and Cancer Promotion: Involvement of Gap Junction Intercellular Communications and Inflammatory Cytokines. Oxid Med Cell Longev. 2017;2017:7028583; doi: 10.1155/2017/7028583.

Pamphlett R, Colebatch AJ, Doble PA, Bishop DP. Mercury in Pancreatic Cells of People with and without Pancreatic Cancer. Int J Environ Res Public Health. 2020;17(23).

DOI: 10.3390/ijerph17238990

Wei Z, Song X, Shaikh ZA. Cadmium promotes the proliferation of triple-negative breast cancer cells through EGFR-mediated cell cycle regulation. Toxicol Appl Pharmacol. 2015;289(1):98–108.

DOI: 10.1016/j.taap.2015.09.006

Kolluru V, Tyagi A, Chandrasekaran B, Damodaran C. Profiling of differentially expressed genes in cadmium-induced prostate carcinogenesis. Toxicol Appl Pharmacol. 2019;375:57–63.

DOI: 10.1016/j.taap.2019.05.008

Marima R, Hull R, Dlamini Z, Penny C. Efavirenz and Lopinavir/Ritonavir Alter Cell Cycle Regulation in Lung Cancer. Front Oncol. 2020;10:1693.

DOI: 10.3389/fonc.2020.01693

International Agency for Research on Cancer. Cadmium and cadmium compounds. Rep Carcinog Carcinog Profiles. 2011;12:80–83.

Rezapour M, Rezapour HA, Chegeni M, Khanjani N. Exposure to cadmium and head and neck cancers: A meta-analysis of observational studies. Rev Environ Health. 2021;36(4):577–584.

DOI: 10.1515/reveh-2020-0109

Louboutin J-P, Strayer D. Role of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant Enzymes. Antioxidants (Basel, Switzerland). 2014;3(4):770–797.

DOI: 10.3390/antiox3040770

Hartwig A. Cadmium and Its Impact on Genomic Stability. In: Cadmium Interaction with Animal Cells Springer. 2018;107–125.

Anetor JI. Rising environmental cadmium levels in developing countries: threat to genome stability and health. Niger J Physiol Sci. 2012;27(2):103–115.

Asemota EA, Okafor IM, Okoroiwu HU, Ekong ER, Anyanwu SO, Efiong EE, et al. Zinc, copper, CD4 T-cell count and some hematological parameters of HIV-infected subjects in Southern Nigeria. Integr Med Res. 2018;7(1):53–60.

DOI: 10.1016/j.imr.2018.01.008

Martinez SS, Campa A, Li Y, Fleetwood C, Stewart T, Ramamoorthy V, et al. Low Plasma Zinc Is Associated with Higher Mitochondrial Oxidative Stress and Faster Liver Fibrosis Development in the Miami Adult Studies in HIV Cohort. J Nutr. 2017; 147(4):556–562.

DOI: 10.3945/jn.116.243832

Osuna-Padilla IA, Briceño O, Aguilar-Vargas A, Rodríguez-Moguel NC, Villazon-De la Rosa A, Pinto-Cardoso S, et al. Zinc and selenium indicators and their relation to immunologic and metabolic parameters in male patients with human immunodeficiency virus. Nutrition. 2020;70: 110585.

DOI: 10.1016/j.nut.2019.110585.

Dirajlal-Fargo S, Yu J, Kulkarni M, Sattar A, Funderburg N, Barkoukis H, et al. Brief Report: Zinc Supplementation and Inflammation in Treated HIV. J Acquir Immune Defic Syndr. 2019;82(3):275–280.

DOI: 10.1097/QAI.0000000000002129.

Sakurai K, Furukawa S, Katsurada T, Otagiri S, Yamanashi K, Nagashima K, et al. Effectiveness of administering zinc acetate hydrate to patients with inflammatory bowel disease and zinc deficiency: a retrospective observational two-center study. Intest Res; 2021. DOI: 10.5217/ir.2020.00124.